Sign In
Buy EGRX
$0.460
+0 (+0%)
At Close: Jun 03, 2026
Eagle Pharmaceuticals (EGRX) Lags Q4 Earnings and Revenue Estimates
09:45am, Monday, 07'th Mar 2022
Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of -2.30% and 10.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stoc
Eagle Pharmaceuticals Q4 2021 Earnings Preview
05:10pm, Friday, 04'th Mar 2022 Seeking Alpha
Eagle Pharmaceuticals (NASDAQ:EGRX) is scheduled to announce Q4 earnings results on Monday, March 7th, before market open.The consensus EPS Estimate is $0.94 (-2.1% Y/Y) and the…
Why Shares of Endo International Slumped 22.8% on Tuesday
09:45pm, Tuesday, 01'st Mar 2022 The Motley Fool
The company's shares are down more than 36% so far this year.
Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results on March 7, 2022
11:50am, Thursday, 24'th Feb 2022 GlobeNewswire Inc.
WOODCLIFF LAKE, N.J., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2021 fourth qu
Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results on March 7, 2022
06:50am, Thursday, 24'th Feb 2022
WOODCLIFF LAKE, N.J., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2021 fourth quar
TEVA Stock Up on Q4 Earnings Beat, Sales Miss Estimates
04:43pm, Thursday, 10'th Feb 2022 Zacks Investment Research
Shares of TEVA rise 8.4% after the company beat earnings estimates despite missing on sales for fourth-quarter 2021. It issues its financial guidance for 2022.
What's in the Cards for Henry Schein (HSIC) in Q4 Earnings?
02:35pm, Thursday, 10'th Feb 2022 Zacks Investment Research
Solid demand in the global dental market along with an increase in COVID-19 test demand are likely to have contributed to Henry Schein's (HSIC) Q4 performance.
Pemetrexed Market Huge Growth in Future Scope 2022-2028 | Eli Lilly and Company, Stada Arzneimittel AG, Eagle Pharmaceuticals, Inc.
10:15am, Thursday, 10'th Feb 2022 OpenPR
Coherent Market Insights published a business research report on Pemetrexed Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 20222028. Pemetrexed Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand
Eagle Pharma reports commercial availability of Pemfexy (NASDAQ:EGRX)
01:25pm, Tuesday, 01'st Feb 2022 Seeking Alpha
Eagle Pharmaceuticals (EGRX) announces the commercial availability of its novel product Pemfexy (pemetrexed for injection).A branded alternative to Eli Lilly''s Alimta, Eagles PEMFEXY is
Philips' (PHG) Q4 Earnings Hit By Supply-Chain Issues, Recall
04:20pm, Wednesday, 12'th Jan 2022 Zacks Investment Research
Philips (PHG) fourth-quarter and 2021 results suffer from supply-chain constraints and adverse impact of the Respironics recall.
Eagle Pharmaceuticals Shares Turn Positive After Positive 2022 Outlook
06:55pm, Wednesday, 05'th Jan 2022 MarketWatch
By Chris Wack Eagle Pharmaceuticals Inc. shares pushed into positive territory Wednesday after the company said it expects significant revenue growth this
Eagle Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
04:30pm, Monday, 03'rd Jan 2022
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, President and Chief Executive Officer, and Bria
Zacks.com featured highlights include: Summit Hotel Properties, Meritage Homes, Eagle Pharm and BrightSphere Investment Group
10:41am, Monday, 27'th Dec 2021 Zacks Investment Research
Zacks.com featured highlights include: Summit Hotel Properties, Meritage Homes, Eagle Pharm and BrightSphere Investment Group
4 High Earnings Yield Stocks Likely to Pay Off Big Time
10:44am, Thursday, 23'rd Dec 2021
Summit Hotel (INN), Meritage Homes (MTH), Eagle Pharmaceuticals (EGRX) and BrightSphere (BSIG) could be some attractive bets if you are looking for high earnings yield picks.
Eagle Pharmaceuticals (EGRX) Upgraded to Buy: Here's What You Should Know
05:00pm, Wednesday, 22'nd Dec 2021 Zacks Investment Research
Eagle Pharmaceuticals (EGRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
